This company seems to have been delisted
Reason: Acquired by Novo Holdings
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Reason: Acquired by Novo Holdings
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Catalent
CTLT
$63.48
Share price
0.00%
Change (1 day)
13.78%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Earnings for Catalent (CTLT)
Earnings in 2024 (TTM): -$91 Million USD
According to Catalent's latest financial reports the company's current earnings are $4.42 Billion USD. In 2023 the company made an earning of -$1.21 Billion USD a decrease over its 2022 earnings that were of $0.64 Billion USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Catalent from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | -$91 Million | -92.46% |
| 2023 | -$1.21 Billion | -286.27% |
| 2022 | $0.64 B | -25.81% |
| 2021 | $0.87 B | 77.66% |
| 2020 | $0.49 B | 62.46% |
| 2019 | $0.30 B | 10.64% |
| 2018 | $0.27 B | 18.66% |
| 2017 | $0.23 B | 9.14% |
| 2016 | $0.21 B | -15.11% |
| 2015 | $0.24 B | 15.35% |
| 2014 | $0.21 B | 10.45% |
| 2013 | $0.19 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | $97.87 M | -207.55% | 🇺🇸 USA |
 | -$23.25 Million | -74.46% | 🇺🇸 USA |
 | $0.47 B | -616.87% | 🇮🇪 Ireland |
 | -$58.01 Million | -36.25% | 🇺🇸 USA |